Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
17.34
+0.01 (0.06%)
At close: Oct 13, 2026, 4:00 PM EDT
17.33
-0.01 (-0.06%)
After-hours: Oct 13, 2026, 6:15 PM EDT
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year. That makes Bicara Therapeutics the 31,189th largest employer in the world and 4,014th in the United States.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,799,641
Market Cap
1.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 465 |
| Janux Therapeutics | 113 |
| ORIC Pharmaceuticals | 111 |
| Nanobiotix | 100 |
| Vor Biopharma | 76 |
| Savara | 70 |
| Avalyn Pharma | 55 |
| Damora Therapeutics | 7 |
BCAX News
- 8 days ago - Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 month ago - BMO starts Bicara at Outperform, sees meaningful upside potential - TheFly
- 1 month ago - Bicara Therapeutics initiated with an Outperform at BMO Capital - TheFly
- 1 month ago - Bicara Therapeutics price target lowered to $34 from $35 at BofA - TheFly
- 1 month ago - Bicara Therapeutics price target raised to $20 from $18 at Goldman Sachs - TheFly
- 1 month ago - Bicara Therapeutics price target raised to $39 from $28 at BTIG - TheFly
- 1 month ago - Bicara Therapeutics price target raised to $20 from $18 at Mizuho - TheFly